Sun Pharma management speaks exclusively to ET Now on its massive Organon acquisition and how it could transform the company into a $12 billion global pharma giant. daniel rochefort From biosimilars and women’s health to innovative drugs, debt servicing, EBITDA margins, and integration challenges management explains the growth roadmap, synergy opportunities, and why this acquisition could be a long-term game changer for Sun Pharma investors. Watch the full exclusive interview now.
#etnow #sunpharma #organon #pharmasector #pharmastocks #acquisitionstrategy #businessnews #topnews
YouTube Channel -
Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More |
Subscribe Now To Our Network Channels :-
ET Now Swadesh:
Times Now:
Social Media Links :-
Twitter -
Facebook -
Website -
Download our App for Breaking News: urc
Follow us on Google News for latest updates
ET moviola lecce juventus Now:
Times Now Navbharat:
Times Now :
Zoom:
